HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.

Abstract
Phytogenic compounds with anti-oxidant and anti-inflammatory properties, such as ginsenoside metabolite compound K (CK) or berberine (BBR), are currently discussed as promising complementary agents in the prevention and treatment of cancer and inflammation. The latest study showed that ginsenoside Rb1 and its metabolites could inhibit TNBS-induced colitis injury. However, the functional mechanisms of anti-inflammation effects of ginsenoside, particularly its metabolite CK are still not clear. Here, using dextran sulfate sodium (DSS)-induced colitis in mice, clinical parameters, intestinal integrity, pro-inflammatory cytokines production, and signaling pathways in colonic tissues were determined. In mild and sever colitis mice, CK and BBR (as a positive agent) alleviated colitis histopathology injury, ameliorated myeloperoxidase (MPO) activity, reduced pro-inflammatory cytokines production, such as, IL-6, IL-1β, TNF-α, and increased anti-inflammatory cytokine IL-10 production in both mice colon tissues and blood. Nevertheless, the results revealed that CK and BBR inhibited NF-κB p65 nuclear translocation, downregulated p-IκBα and upregulated IκBα, indicating that CK, as well as BBR, suppressed the activation of the NF-κB pathway in the progression of colitis with immunofluorescence, immunohistochemical and western blotting analysis. Furthermore, CK inhibited pro-inflammatory cytokines production in LPS-activated macrophages via down-regulation of NF-κB signaling pathway. Taken together, our results not only reveal that CK promotes the recovery of the progression of colitis and inhibits the inflammatory responses by suppressing NF-κB activation, but also suggest that CK downregulates intestinal inflammation through regulating the activation of macrophages and pro-inflammatory cytokines production.
AuthorsJuan Li, Wei Zhong, Weiwei Wang, Shaoping Hu, Jiahui Yuan, Bing Zhang, Tianhui Hu, Gang Song
JournalPloS one (PLoS One) Vol. 9 Issue 2 Pg. e87810 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24504372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Berberine
  • Dextran Sulfate
  • Peroxidase
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, pharmacology)
  • Berberine (administration & dosage, pharmacology)
  • Cell Line
  • Colitis (chemically induced, drug therapy, immunology, metabolism, pathology)
  • Colon (immunology, metabolism, pathology)
  • Cytokines (biosynthesis)
  • Dextran Sulfate (adverse effects)
  • Disease Models, Animal
  • Inflammation Mediators (metabolism)
  • Macrophages (drug effects, immunology, metabolism)
  • Mice
  • NF-kappa B (metabolism)
  • Peroxidase (blood, metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: